Recruitment is underway, with operations expected by mid-2025. LCCI Hyderabad will be Lilly's second capability center in India, after the launch of LCCI Bengaluru in 2016, the company stated. 'Silent ...

Hyderabad: Singapore's CapitaLand Group, one of Asia's largest real estate investment and development company, has announced Rs 450 crore investment to develop a state-of-the-art one million sq ft ...

Hyderabad: The Hyderabad Metro Rail created a green corridor facilitating the swift and seamless transportation of a donor heart, covering a distance of 13 kilometers in 13 minutes across 13 ...

Hyderabad: "Hyderabad is a city where minarets meet microchips, where heritage walks alongside innovation, and where biryani fumes mix with the buzz of start-ups. It is a living tapestry of ...

Revanth Reddy. The upcoming project, part of CapitaLand’s broader development pipeline in Hyderabad, is expected to reinforce the city’s position as a leading business and technology hub.

Ravi Teja, an Indian student from Hyderabad studying in the US, was shot dead in New Haven, Connecticut. His family and Indian authorities are working to repatriate his body. The incident has ...

A 26-year-old student from Hyderabad has been shot dead in Washington, United States. The victim, identified as K. Ravi Teja, hailed from R.K. Puram in the Chaitanyapuri. He had travelled to the U ...

Bank of America Securities analyst Tim Anderson maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s shares closed last Friday at $725.72. According to ...

Oak Ridge Investments LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 6.2% during the fourth quarter, according to its most recent Form 13F filing with the ...

Hyderabad: The HMWS&SB has attributed the surge in water tanker bookings to the rapidly depleting groundwater level. Talking to Deccan Chronicle, K. Ashok Reddy, MD of HMWS&SB, said, “Bore wells ...

Eli Lilly's stock price finished Jan. 16 down 21% from a peak it set last September. The sales trajectory of Mounjaro and Zepbound tapered off in the second half of 2024. An oral weight-loss ...

GLP-1 drugs have become all the rage for weight loss, with sales for drugs like Novo Nordisk's Ozempic and Eli Lilly's (NYSE: LLY) Mounjaro skyrocketing over the past year. However, Eli Lilly ...